0001127602-17-031878.txt : 20171113 0001127602-17-031878.hdr.sgml : 20171110 20171113153523 ACCESSION NUMBER: 0001127602-17-031878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171108 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calzavara Marco G. CENTRAL INDEX KEY: 0001517049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 171195607 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-11-08 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001517049 Calzavara Marco G. 3471 RIVER HILLS DRIVE CINCINNATI OH 4524 1 Pres & Managing Director, MBE Common Stock 2017-11-08 4 A 0 8000 0 A 64057 D Common Stock 2017-11-09 4 D 0 10000 0 D 54057 D These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021. These restricted stock units were awarded under the 2012 Stock Incentive Plan and were subject to attainment by the Company of a specified earnings target for fiscal 2017. As the Company did not reach the target, these restricted stock units have been cancelled. /s/ Melissa A. Lueke as Attorney-in-Fact for Marco Calzavara 2017-11-13